Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Am J Cardiol. 2019 Jul 17;124(7):1149–1158. doi: 10.1016/j.amjcard.2019.06.032

Table 2:

Electrocardiographic parameter summary

Variable Case Block 1 (n = 91) Control Block 1 (n = 1783) p-value c Case block 1 (n = 85 d) Case block 2 (n = 85 d) p-value e
Arrhythmias, n(%)
 AF, any in block n 31 (34%) 373 (20%) 0.0029 30 (35%) 17 (24%) 0.0258
 AF, present block n not block n-1 13 (14%) 64 (3%) <0.0001 13 (15%) 3 (4%) 0.0086§
 2° HB, any in block n 36 (40%) 332 (18%) <0.0001 33 (39%) 7 (10%) <0.0001f
 2° HB, present block n not block n-1 26 (29%) 162 (3%) <0.0001 26 (31%) 3 (4%) <0.0001f
 Pauses, any in block n 30 (33%) 376 (20%) 0.0073 30 (35%) 8 (12%) <0.0001f
 Pauses, present block n not block n-1 22 (24%) 229 (12%) 0.0020 22 (26%) 5 (7%) 0.0004§
Trend Slope (Δyn/Δxn)b, median (IQR)
 QRS Amplitude Averaged + (μV/hr) 321 (119 – 641) 312 (138 – 627) NS 305 (119 – 623) 223 (118 – 447) NS
 QRS Amplitude Averaged + (μV/hr) 310 (125 – 613) 285 (137 – 608) NS 243 (122 – 608) 210 (97 – 499) NS
 PR Interval + (ms/hr)a 8.0 (4.5 – 14.1) 6.7 (3.6 – 12.6) NS 5.9 (3.7 – 9.3) 8.0 (3.9 – 16.2) NS
 PR Interval − (ms/hr)a 9.5 (4.3 – 20.0) 6.7 (3.7 – 13.4) 0.0466 6.5 (3.5 – 20.5) 7.6 (3.6 – 13.0) NS
 QRS Duration + (ms/hr) 6.5 (2.8 – 13.6) 4.2 (1.8 – 8.6) 0.0020 8.1 (3.3 – 14.1) 3.6 (1.9 – 7.8) 0.0488
 QRS Duration − (ms/hr) 5.5 (3.0 – 13.2) 3.7 (1.6 – 8.1) 0.0011 5.3 (3.0 – 13.3) 4.2 (1.9 – 8.1) 0.0019f
 QTc + (ms/hr) 16.9 (8.3 – 37.3) 13.9 (7.6 – 27.5) NS 16.7 (8.8 – 32.2) 13.5 (7.4 – 25.6) NS
 QTc − (ms/hr) 16.4 (9.5 – 53.3) 13.3 (6.9 – 25.5) 0.0086 15.6 (8.8 – 54.4) 12.7 (7.2 – 36.5) NS
 RR + (ms/hr) 48.8 (26.5 – 76.1) 52.8 (27.2 – 98.2) NS 40.8 (26.4 – 75.9) 40.6 (19.0 – 69.5) NS
 RR − (ms/hr) 45.1 (23.2 – 96.4) 53.8 (25.6 – 112.9) NS 42.0 (18.5 – 90.4) 32.9 (15.9 – 65.6) NS
 ST Lead II + (μV/hr) 28.6 (13.1 – 67.1) 15.0 (7.8 – 29.0) <0.0001 29.1 (12.9 – 66.4) 20.1 (8.6 – 37.9) 0.0020f
 ST Lead II − (μV/hr) 28.5 (14.0 – 48) 15.0 (8.0 – 30.4) <0.0001 27.0 (14.0 – 47) 20.5 (8.3 – 35.5) NS
 ST Lead V2 + (μV/hr) 16.0 (6.2 – 33.5) 10.5 (5.5 – 19.5) 0.0009 16.5 (5.4 – 34.6) 12.6 (6.5 – 26.2) NS
 ST Lead V2 − (μV/hr) 15.8 (6.5 – 33.0) 10.5 (5.3 – 20.7) 0.0060 16.3 (6.6 – 33.0) 11.7 (6.4 – 22.8) NS
Trend Slope Comparison (Δyn/Δxn – Δyn-1/Δxn-1) b, median (IQR)
 QRS Amplitude Averaged + (μV/hr) 43 (−148 – 278) 10 (−212 – 243) NS 69 (−131 – 277) 13 (−155 – 157) NS
 QRS Amplitude Averaged − (μV/hr) 45 (−108 – 238) −4 (−187 – 203) NS 43 (−171 – 301) 23 (−162 – 159) NS
 PR Interval + (ms/hr)a 0.0 (−2.7 – 2.8) 0.2 (−4.8 – 5.1) NS 0.1 (−3.3 – 3.3) −0.7 (−3.7 – 3.1) NS
 PR Interval − (ms/hr)a 1.2 (−2.6 – 7.7) 0.2 (−4.8 – 5.0) 0.0210 0.3 (−4.2 – 7.9) −0.15 (−4.0 – 5.2) NS
 QRS Duration + (ms/hr) 0.4 (−2.6 – 7.1) 0 (−3.7 – 3.9) NS 1.1 (−2.3 – 9.6) −0.1 (−2.8 – 2.2) NS
 QRS Duration − (ms/hr) 1.3 (−2.2 – 5.2) 0.1 (−3.5 – 3.7) 0.0072 2.2 (−1.1 – 6.1) 0.4 (−2.7 – 2.7) 0.0096f
 QTc + (ms/hr) 1.0 (−7.6 – 18.0) 0.3 (−11.0 – 11.3) NS 1.0 (−7.7 – 18.3) 0.1 (−8.9 – 11.4) NS
 QTc − (ms/hr) −2.4 (−7.1 – 21.8) 0.4 (−8.9 – 10.7) NS 0.1 (−7.7 – 23.8) 0.2 (−9.9 – 19.8) NS
 RR + (ms/hr) 3.9 (−23.4 – 29.3) 3.3 (−31.8 – 38.3) NS 2.8 (−24.8 – 25.1) 0.6 (−17.5 – 22.1) NS
 RR − (ms/hr) 3.7 (−16.2 – 37.4) 0.1 (−42.2 – 38.1) NS 3.3 (−15.2 – 37.7) 0.2 (−16.2 – 17.4) NS
 ST Lead II + (μV/hr) 6.3 (−5.4 – 32.3) −0.4 (−11.5 – 11.1) 0.0002 6.3 (−5.4 – 32.3) −1.9 (−9.5 – 18.3) 0.0201
 ST Lead II − (μV/hr) 4.2 (−6.8 – 26.1) −0.2 (−11.7 – 11.1) 0.0029 4.5 (−8.7 – 26.1) 2.0 (−10.7 – 12.8) NS
 ST Lead V2 + (μV/hr) 2.4 (−8.7 – 10.6) −0.1 (−7.9 – 7.7) NS 2.6 (−8.7 – 13.3) 0.8 (−6.5 – 12.7) NS
 ST Lead V2 − (μV/hr) 1.5 (−6.8 – 12.8) 0.0 (−8.2 – 7.0) NS 1.5 (−6.8 – 12.8) 2.3 (−5.2 – 11.1) NS
Trend Change (Δyn) b, median (IQR)
 QRS Amplitude Averaged + (μV) 113 (54 – 181) 86 (47 – 158) NS 102 (54 – 181) 72 (41 – 141) 0.0224
 QRS Amplitude Averaged − (μV) 109 (65 – 165) 85 (48 – 143) 0.0462 98 (48 – 190) 75 (31 – 126) 0.0494
 PR Interval + (ms) a 10 (5 – 15.5) 7 (4 – 14) 0.0347 8 (5 – 14) 9 (5 – 15) NS
 PR Interval − (ms) a 12 (5 – 17) 7 (4 – 14) 0.0270 8 (4 – 18) 9 (4 – 12.5) NS
 QRS Duration + (ms) 9 (4 – 16) 4 (2 – 8) <0.0001 11 (4 – 16) 5 (2 – 12) 0.0005f
 QRS Duration − (ms) 7.5 (3 – 13) 5 (2.8 – 8) 0.0015 8 (3 – 13) 5 (2 – 8) 0.0101f
 QTc + (ms) 24.4 (14.6 – 43.3) 14.6 (8.5 – 26.7) <0.0001 24.1 (11.9 – 44.6) 16.8 (8.4 – 31.3) 0.0035f
 QTc − (ms) 30.1 (11.1 – 56.9) 14.4 (9.0 – 26.0) <0.0001 30.1 (10.5 – 60.6) 16.9 (8.4 – 34.4) 0.0108f
 RR + (ms) 59 (35.5 – 134) 61 (32 – 103) NS 62 (36 – 137) 41 (18 – 70) 0.0024f
 RR − (ms) 61 (28 – 120) 58 (31 – 105) NS 51 (21 – 120) 37 (22 – 71) NS
 ST Lead II + (μV) 32 (15 – 70) 16 (9 – 29.8) <0.0001 34 (15 – 75) 19 (9 – 41) 0.0020f
 ST Lead II − (μV) 30 (14 – 66.5) 16 (9 – 29) <0.0001 30 (14 – 64.5) 20 (12 – 45) 0.0037f
 ST Lead V2 + (μV) 16 (8-33) 11 (6 – 20) 0.0003 18 (8 – 37) 12 (6 – 20) 0.0311
 ST Lead V2 − (μV) 20 (9 – 41) 11 (6 – 20) <0.0001 20 (9 – 41) 12 (6 – 22) 0.0002f
Trend Change Comparison (Δyn-(n-1))b, median (IQR)
 QRS Amplitude Averaged + (μV) 21 (−29 – 77) 0 (−59 – 61) 0.0306 28 (−24 – 93) −3 (−42 – 55) NS
 QRS Amplitude Averaged − (μV) 10 (−22 – 104) 0 (−42 – 49) 0.0239 8 (−34 – 114) 10 (−46 – 38) NS
 PR Interval + (ms)a 0 (−3 – 3) 0 (−5 – 4) NS −1 (−5.5 – 3.5) 0 (−5 – 4) NS
 PR Interval − (ms)a 1 (−1.5 – 4.5) 0 (−4 – 4) NS 2 (−3.5 – 9.5) 0 (−3 – 3) NS
 QRS Duration + (ms) 1 (−1 – 6) 0 (−3 – 3) 0.0004 2 (−2 – 11) 0 (−4 – 3) NS
 QRS Duration – (ms) 1 (−1 – 5.75) 0 (−3 – 3) 0.0069 2 (−1 – 8) −1 (−4.5 – 3) 0.0211
 QTc + (ms) 6 (−6 – 22) 0.7 (−8.3 – 9.3) 0.0365 6 (−6 – 24) 0.8 (−9.4 – 12.9) NS
 QTc − (ms) 7 (−5 – 25) −0.20 (−8.5 – 8.2) 0.0002 7 (−6 – 36) −1.0 (−5.9 – 12.2) NS
 RR + (ms) 21 (−19.5 – 55) 1 (−33 – 37) 0.0010 23 (−18 – 57) −8 (−25 – 23) 0.0019f
 RR − (ms) 12 (−16 – 54) 2 (−31 – 35.5) 0.0220 9 (−21 – 60.5) −4 (−24 – 15) 0.0451
 ST Lead II + (μV) 7 (−7 – 35.5) 0 (−10 – 10) 0.0006 9 (−7.5 – 42) 0 (−9 – 13) NS
 ST Lead II − (μV) 9 (−6 – 30.5) 0 (−10 – 10) <0.0001 9 (−7 – 26) 4 (−6 – 12) NS
 ST Lead V2 + (μV) 2 (−4.5 – 10.5) 0 (−7 – 6) 0.0419 4 (−4 – 18.3) 0 (−8 – 7) NS
 ST Lead V2 − (μV) 6 (−2 – 25.5) 0 (−6 – 7) <0.0001 7.5 (−2 – 26) 0(−6 – 10) 0.0113f

Abbreviations: AF – atrial fibrillation, HB – heart block, IQR – interquartile range

a

Reported where measureable given this is not measureable in atrial fibrillation

b

For each row, + denotes the measure for the dominant positive trend, and − denotes the measure for the dominant negative trend for that ECG parameter. All negative trend change and slope measurements are reported as the absolute value.

c

All univariate comparisons with p-value < 0.05 were also significant at q-value < 0.05, which corrects for false discovery rate due to multiple hypothesis testing

d

This reflects the number of patients who had a block 3 available, as this was required to calculate trend slope and trend change comparison values

e

All trend comparisons were performed using paired comparison with the Wilcoxon signed-rank test

f

These values were significant at the q-value < 0.05 level, which corrects for the false discovery rate due to multiple hypothesis testing